New pharmaceutical uses of staurosporine derivatives

Details for Australian Patent Application No. 2004248909 (hide)

Owner Novartis AG

Inventors Coutre, Steven

Agent Davies Collison Cave

Pub. Number AU-B-2004248909

PCT Pub. Number WO2004/112794

Priority 60/479,575 18.06.03 US

Filing date 17 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 8 May 2008

International Classifications

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/112794 Priority application(s): WO2004/112794

8 May 2008 Application Accepted

  Published as AU-B-2004248909

4 September 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004248911-Infant or follow-on formula

2004248905-Stabiized fruit pulp composition and a puree composition comprising the same